Protective Efficacy of coenzyme Q 10 against DDVP-Induced cognitive impairments and neurodegeneration in rats

Neurotoxicity Research

Volumn 21, Issue 4, 2012, Pages 345-357

  Binukumar, B K ^a   Gupta, Nidhi ^a   Sunkaria, Aditya ^a   Kandimalla, Ramesh ^a   Wani, W Y ^a   Sharma, D R ^a   Bal, Amanjit ^a   Gill, Kiran Dip ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Acetylcholinesterase; DDVP; Memory; Organophosphate; Oxidative damage

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYTOCHROME C OXIDASE; DICHLORVOS; MALONALDEHYDE; MANGANESE SUPEROXIDE DISMUTASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUCCINATE DEHYDROGENASE (UBIQUINONE); UBIDECARENONE; UBIQUINOL CYTOCHROME C REDUCTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN MITOCHONDRION; CHRONIC DRUG ADMINISTRATION; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFICACY; HIPPOCAMPUS; HISTOPATHOLOGY; LIPID PEROXIDATION; LONG TERM EXPOSURE; MALE; MAZE TEST; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RAT; SPATIAL MEMORY;

ANIMALS; AVOIDANCE LEARNING; COGNITION DISORDERS; DICHLORVOS; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; HIPPOCAMPUS; MALE; MAZE LEARNING; MITOCHONDRIA; NERVE DEGENERATION; OXIDATIVE STRESS; PROTON PUMPS; RATS; RATS, WISTAR; UBIQUINONE; VITAMINS;

ANIMALIA; RATTUS;

EID: 84861462191     PISSN: 10298428     EISSN: 14763524     Source Type: Journal    
DOI: 10.1007/s12640-011-9289-0     Document Type: Article

References (44)

1. Atlante A, Gagliardi S, Marra E, Calissano P (1998) Neuronal apoptosis in rats is accompanied by rapid impairment of cellular respiration and is prevented by scavengers of reactive oxygen species. Neurosci Lett 245:127-130 (Pubitemid 28287339)
2. Benoit IG, Lee VM-Y (2000) A new link between pesticides and Parkinson's disease. Nat Neurosci 3:1227-1228
3. Beretta S, Sala G, Mattavelli L, Ceresa C, Casciati A, Ferri A, Carrì MT, Ferrarese C (2003) Mitochondrial dysfunction due to mutant copper/zinc superoxide dismutase associated with amyotrophic lateral sclerosis is reversed by N-acetylcysteine. Neurobiol Dis 13:213-221 (Pubitemid 36937204)
4. Beyer RE (1996) The role of ascorbate in antioxidant protection of biomembranes: Inter-action with vitamin E and coenzyme Q. J Bioenerg Biomembr 26:349-358 (Pubitemid 24321060)
5. Beyer RE, Segura-Aguilar J, Di Bernardo S, Cavazzoni M, Fato R, Fiorentini D, Galli MC, Setti M, Landi L, Lenaz G (1996) The role of DT-diaphorase in the maintenance of the reduced antioxidant form of coenzyme Q in membrane systems. Proc Natl Acad Sci USA 93:2528-2532 (Pubitemid 26104381)
6. Bharath S, Hsu M, Kaur D, Rajagopalan S, Andersen JK (2002) Glutathione, iron and Parkinson's disease. Biochem Pharmacol 64:1037-1048 (Pubitemid 35232279)
7. Binukumar BK, Bal A, Kandimalla R, Sunkaria A, Gill KD (2010) Mitochondrial energy metabolism impairment and liver dysfunction following chronic exposure to dichlorvos. Toxicology 270(2-3):77-84
8. Chen CM, Yin MC, Hsu CC, Liu TC (2007) Antioxidative and antiinflammatory effects of four cysteine-containing agents in striatum of MPTP-treated mice. Nutrition 23:589-597
9. Cleren C, Yang L, Lorenzo B, Calingasan NY, Schomer A, Sireci A, Wille EJ, Beal MF (2008) Therapeutic effects of coenzyme Q10 (CoQ10) and reduced CoQ10 in the MPTP model of Parkinsonism. J Neurochem 104:1613-1621 (Pubitemid 351316765)
10. De Bustos F, Molina JA, Jimenez-Jimenez FJ, Garcia-Redondo A, Gomez-Escalonilla C, Porta-Etessam J (2000) Serum levels of coenzyme Q10 in patients with Alzheimer's disease. J Neural Transm 107(2):233-239 (Pubitemid 30095372)
11. Ernster L, Dallner G (1995) Biochemical, physiological and medical aspects of ubiquinone function. Biochim Biophys Acta 24:95-204
12. Ferrante RJ, Andreassen OA, Dedeoglu A, Ferrante KL, Jenkins BG, Hersch SM (2002) Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease. J Neurosci 22:1592-1599 (Pubitemid 35386278)
13. Grieb P, Ryba MS, Sawicki J, Chrapusta SJ (1997) Oral coenzyme Q10 administration prevents the development of ischemic brain lesions in a rabbit model of symptomatic vasospasm. Acta Neuropathol (Berl) 94(4):363-368 (Pubitemid 27450117)
14. Guillette EA, Meza M, Aquilar MG, Soto AD, Garcia IE (1998) An anthropological approach to the evaluation of preschool children exposed to pesticides in Mexico. Environ Health Perspect 106:347-353 (Pubitemid 28365050)
15. Kaur P, Radotra Bishan, Minz Ranjana, Gill KD (2007) Impaired mitochondrial energy metabolism and neuronal apoptotic cell death after chronic DDVP (OP) exposure in rat brain. Neuro- Toxicology 28:1208-1219 (Pubitemid 350026599)
16. King TE, Howard RL (1967) Preparation and properties of soluble NADH dehydrogenase from cardiac muscle. In: Colowick SP, Kaplan NO (eds) Methods in enzymology. Academic Press, New York, pp 275-276
17. Kochs E, Werner C (1995) Neuroprotection: Fact or fantasy? Eur J Anaesthesiol 10(Suppl.):67-70
18. Kumar V, Bal A, Gill KD (2009) Susceptibility of mitochondrial superoxide dismutase to aluminium induced oxidative damage. Toxicology 255:117-123
19. Levin ED, Addy N, Baruah A, Elias A, Christopher NC, Seidler FJ (2002) Prenatal chlorpyrifos exposure in rats causes persistent behavioral alterations. Neurotoxicol Teratol 24:733-741 (Pubitemid 35375777)
20. Li H, Klein G, Sun P, Buchan AM (2000) CoQ10 fails to protect brain against focal and global ischemia in rats. Brain Res 877(1):7-11
21. Lodi R, Iotti S, Scorolli L, Scorolli L, Bargossi AM, Sprovieri L, Zaniol P, Meduri R, Barbiroli B (1994) The use of phosphorus magnetic resonance spectroscopy to study in vivo the effect of coenzyme Q10 treatment in retinitis pigmentosa. Mol Aspects Med 15(suppl.):221-230
22. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin-phenol reagent. J Biol Chem 193:265-275
23. MacMillan-Crow LA, Crow JP, Kerby JD, Beckman JS, Thompson JA (1966) Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proc Natl Acad Sci USA 93:11853-11858
24. Matthews RT, Yang L, Browne S, Baik M, Beal MF (1998) Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. Proc Natl Acad Sci USA 95(15):8892-8897
25. Morris RGM (1984) Development of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11:47-60
26. Nelson LM (1995) Epidemiology of ALS. Clin Neurosci 3:327-331
27. Okamoto F, Allen BS, Buckberg GD (1986) Reperfusate composition: Supplemental role of intravenous and intracoronary coenzyme Q10 in avoiding reperfusion damage. J Thorac Cardiovasc Surg 92:573
28. Ostrowski RP (1999) Effect of coenzyme Q10 (CoQ10) on superoxide dismutase activity in ET-1 and ET-3 experimental models of cerebral ischemia in the rat. Folia Neuropathol 37(4):247-251
29. Ostrowski RP (2000) Effect of coenzyme Q(10) on biochemical and morphological changes in experimental ischemia in the rat brain. Brain Res Bull 53(4):399-407 (Pubitemid 32000816)
30. Piala JJ, High JP, Hessert JLJ, Burke JC, Crower BN (1959) Pharmacological and acute toxicological comparisons of trifluoropromazine and chlorpromazine. J Pharmacol Exp Ther 127:55-65
31. Ray DE, Richards PG (2004) The potential for toxic effects of chronic, low-dose exposure to organophosphates. Toxicol Teratol 120:343-351
32. Reed JC, Jurgensmeyer JM, Matsuyama S (1998) Bcl-2 family proteins and mitochondria. Biochim Biophys Acta 366:127-137 (Pubitemid 28467027)
33. Shults CW, Haas RH, Passov D, Beal MF (1997) Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects. Ann Neurol 42:261-264 (Pubitemid 27340475)
34. Shults CW, Oakes D, Kieburtz K, Beal MF, Haas R, Plumb S et al (2002) Effects of coenzyme Q10 in early Parkinson disease: Evidence of slowing of the functional decline. Arch Neurol 59(10):1541-1550
35. Shults CW, Haas R, Oakes D, Kieburtz K, Plumb S, Shoulson I et al (2004) Measuring the effects of therapy in Parkinson disease. JAMA 291(20):2430-2431 (Pubitemid 38669182)
36. Sohmiya M, Tanaka M, Tak NW, Yanagisawa M, Tanino Y, Suzuki Y et al (2004) Redox status of plasma coenzyme Q10 indicates elevated systemic oxidative stress in Parkinson's disease. J Neurol Sci 223:161-166 (Pubitemid 39164358)
37. Somayajulu-Niţu M, Sandhu JK, Sikorska M, Sridhar TS, Matei A (2009) Paraquat induces oxidative stress, neuronal loss in substantia nigra region and Parkinsonism in adult rats: Neuroprotection and amelioration of symptoms by water-soluble formulation of coenzyme Q10. BMC Neurosci 10(88):1-12
38. Sottocasa GL, Kuylenstierna B, Ernster L, Bergstrand A (1967) An electron transport system associated with the outer membrane of liver mitochondria. J Cell Biol 32:415-438
39. Steenland K (1996) Chronic neurological effects of organophosphate pesticides. Br Med J 312:1312-1313 (Pubitemid 26158297)
40. Terry AV Jr., Stone JD, Buccafusco JJ, Sickles DW, Sood A, Prendergast MA (2003) Repeated exposures to subthreshold doses of chlorpyrifos in rats: Hippocampal damage, impaired axonal transport, and deficits in spatial learning. J Pharmacol Exp Ther 305:375-384 (Pubitemid 36373874)
41. Tsukahara Y, Wakatsuki A, Okatani Y (1999) Antioxidant role of endogenous coenzyme Q against the ischemia and reperfusioninduced lipid peroxidation in fetal rat brain. Acta Obstet Gynecol Scand 78(8):669-674 (Pubitemid 29392669)
42. Verma SK, Raheja G, Gill KD (2009) Role of muscarinic signal transduction and CREB phosphorylation in dichlorvos-induced memory deficits in rats: An acetylcholine independent mechanism. Toxicology 256(3):175-182
43. Walf AA, Frye CA (2007) The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc 2:32-328
44. Wills ED (1966) Mechanisms of lipid peroxide formation in animal tissues. J Biochem 99:667-676